IL-18BP ANTAGONIST ANTIBODIES AND THEIR USE IN MONOTHERAPY AND COMBINATION THERAPY IN THE TREATMENT OF CANCER

The present invention is directed to anti-IL18-BP antibodies and uses thereof. The present invention is directed to monotherapy and combination treatments with for example immune checkpoint inhibitor antibodies, as described herein.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Nielson, Nels P, Leiderman, Olga, Chiasson, Alissa M, Cohen, Nadav, Frenkel, Masha, Novik, Amit, Cohen, Keren, Fridman-Kfir, Tal, Menachem, Assaf, Blat, Dan, Ophir, Eran, Galperin, Moran, Granit, Roy, Cojocaru, Gad, Alteber, Zoya, Sever, Lital, Faigenbloom, Lior, Toporik, Amir, Vols, Sandra, Tilleman, Hadas Galon
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to anti-IL18-BP antibodies and uses thereof. The present invention is directed to monotherapy and combination treatments with for example immune checkpoint inhibitor antibodies, as described herein.